Newsroom | 39553 results

LYON, France--(BUSINESS WIRE)--ENYO Pharma (« ENYO »), société de biotechnologie en phase clinique spécialisée dans le développement d'agonistes FXR pour le traitement des maladies rénales sévères, a annoncé aujourd'hui la poursuite harmonieuse de son essai de phase 2 ALPESTRIA-1 mené auprès de 26 patients atteints du syndrome d'Alport. Les premiers résultats de l'essai sont attendus au quatrième trimestre 2025. Parallèlement, ENYO a finalisé son tour de financement de série C avec un investiss...

LYON, France--(BUSINESS WIRE)--ENYO Pharma (“ENYO”), a clinical-stage biotechnology company focused on developing FXR agonists for the treatment of severe kidney diseases, today announced the smooth continuation of its Phase 2 ALPESTRIA-1 trial in 26 Alport syndrome patients. The topline results from the trial are on track for the fourth quarter of 2025. In parallel, ENYO has finalized its Series C financing round with a €6 million investment from Vesalius Biocapital IV, bringing the total Seri...

PARIS--(BUSINESS WIRE)--SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today announced the signature with SATT Conectus of an exclusive collaboration and worldwide license agreement for potent monoclonal antibodies targeting the BK virus. These monoclonal antibodies were developed through the project HuMAB...

PARIS--(BUSINESS WIRE)--SpikImm, société de biotechnologie au stade clinique fondée en 2021 par Truffle Capital en collaboration avec l'Institut Pasteur et dédiée au développement d'anticorps monoclonaux pour prévenir les infections virales chez les patients immunodéprimés, annonce aujourd'hui la signature avec la SATT Conectus d'un accord exclusif de collaboration et d’un accord de licence mondiale pour des anticorps monoclonaux puissants ciblant le virus BK. Ces anticorps monoclonaux ont été...

HELSINKI--(BUSINESS WIRE)--Mehiläinen Yhtiöt Oy Announces Pricing of Senior Secured Notes Offering...

ORANGE, Calif.--(BUSINESS WIRE)--Sonrava Health, a leading organization committed to delivering exceptional patient care and improving health outcomes, is proud to announce two strategic additions to its executive leadership team. Mariah Machnikowski has joined the company as Chief Human Resources Officer, and Greg Michelini has been appointed Chief Information Officer. These hires reflect the company’s continued investment in people and innovation as it scales to meet growing demand across its...

BETHESDA, Md.--(BUSINESS WIRE)--BrainScope Expands Board and Launches Advanced Deep Learning Platform to Enhance Brain Health Insights...

BETHESDA, Md. & PROVIDENCE, R.I.--(BUSINESS WIRE)--LucyRx, an independent, next-generation pharmacy benefits manager (PBM), and Personify Health®, the company making healthier easier, today announced a strategic partnership to offer employers a more personalized, clinically grounded approach to GLP-1 medication management and weight care. Through the partnership, LucyRx and Personify Health will deliver an integrated solution that combines pharmacy benefit strategy with personalized support fro...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--GHLF presents innovative digital solutions designed to address suboptimal treatment and enhance disease management...

CHICAGO--(BUSINESS WIRE)--IFT is hosting a free webinar on July 2 that will help food and beverage professionals overcome federal research funding cuts....